Repligen Corporation
RGEN
$155.70
-$4.41-2.75%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 154.87M | 158.84M | 153.18M | 166.62M | 141.19M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 154.87M | 158.84M | 153.18M | 166.62M | 141.19M |
| Cost of Revenue | 75.90M | 76.80M | 75.83M | 80.46M | 81.92M |
| Gross Profit | 78.97M | 82.04M | 77.35M | 86.16M | 59.27M |
| SG&A Expenses | 73.94M | 65.31M | 61.10M | 57.20M | 54.32M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 159.55M | 152.40M | 148.01M | 147.86M | 146.78M |
| Operating Income | -4.68M | 6.44M | 5.17M | 18.76M | -5.59M |
| Income Before Tax | -1.15M | 9.03M | 3.70M | 1.87M | 11.38M |
| Income Tax Expenses | -495.00K | 3.31M | 399.00K | 18.32M | -5.54M |
| Earnings from Continuing Operations | -654.00K | 5.71M | 3.30M | -16.45M | 16.92M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -654.00K | 5.71M | 3.30M | -16.45M | 16.92M |
| EBIT | -4.68M | 6.44M | 5.17M | 18.76M | -5.59M |
| EBITDA | 12.72M | 23.42M | 22.08M | 36.02M | 10.42M |
| EPS Basic | -0.01 | 0.10 | 0.06 | -0.29 | 0.30 |
| Normalized Basic EPS | 0.02 | 0.11 | 0.06 | 0.26 | 0.01 |
| EPS Diluted | -0.01 | 0.10 | 0.06 | -0.29 | 0.30 |
| Normalized Diluted EPS | 0.02 | 0.11 | 0.06 | 0.26 | 0.01 |
| Average Basic Shares Outstanding | 56.01M | 55.88M | 55.79M | 55.82M | 55.77M |
| Average Diluted Shares Outstanding | 56.01M | 56.43M | 56.53M | 55.82M | 56.94M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
